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Abstract:  27 
Purpose: To evaluate the effectiveness of a self-managed home-based moderate intensity walking 28 
intervention on psychosocial health outcomes among breast cancer patients undergoing 29 
chemotherapy. 30 
Methods: The randomised controlled trial compared a self-managed, home-based walking 31 
intervention to usual care alone among breast cancer patients receiving chemotherapy. Outcome 32 
measures included changes in self-report measures of anxiety, depression, fatigue, self-esteem, mood 33 
and physical activity.  Fifty participants were randomised to either the intervention group (n=25), who 34 
received 12 weeks of moderate intensity walking, or the control group (n=25) mid-way through 35 
chemotherapy. Participants in the intervention group were provided with a pedometer and were asked 36 
to set goals and keep weekly diaries outlining the duration, intensity and exertion of their walking. 37 
Levels of psychosocial functioning and physical activity were assessed pre and post intervention in 38 
both groups.  39 
Results: The intervention had positive effects on fatigue (F = 5.77, p = 0.02), self-esteem (F = 8.93, 40 
p<0.001), mood (F = 4.73, p = 0.03) and levels of physical activity (x² = 17.15, p = 0.0011) but not 41 
anxiety (F = 0.90, p = 0.35) and depression (F = 0.26, p = 0.60) as assessed using the HADS. We 42 
found an 80% adherence rate to completing the 12 week intervention and recording weekly logs.   43 
Conclusion: This self-managed, home-based intervention was beneficial for improving psychosocial 44 
well-being and levels of physical activity among breast cancer patients treated with chemotherapy.  45 
 46 
 47 
Keywords:  Breast cancer; Chemotherapy; Physical activity; Walking; Emotional distress; Psycho-48 
social well-being. 49 
50 
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Introduction:  51 
Fatigue, anxiety and depression are the most commonly reported psychosocial difficulties experienced 52 
by breast cancer patients. They can be evident for years after the completion of treatment [1] and can 53 
have a negative impact on the overall quality of life of breast cancer patients and survivors [2]. As 54 
these side effects are becoming more prominent and the number of patients surviving cancer is 55 
increasing, the focus of research has shifted towards improving the length of survival and quality of 56 
life [3].   57 
A number of interventions including cognitive behavioural therapies, psycho-education, individual 58 
counselling, psychotherapy and social support [4,5] have been introduced to help breast cancer 59 
patients manage symptoms associated with poor psychosocial well-being, such as anxiety, depression 60 
and quality of life. However, although the implementation of these interventions have demonstrated 61 
positive outcomes for addressing emotional distress experienced by patients, they fail to account for 62 
physical and functional difficulties encountered by patients, such as fatigue [6]. Physical activity 63 
addresses a broad range of health-related quality of life experienced by breast cancer patients [7,8] 64 
and therefore may be a more effective intervention method. Participation in physical activity 65 
following a diagnosis of breast cancer  has also been found to reduce the risk of cancer recurrence and 66 
improve the survival rates of cancer patients [9].  Physical activity such as walking, cycling, aerobics, 67 
resistance training, yoga and Qigong have shown positive effects in improving psychosocial  health 68 
outcomes such as fatigue and depression in breast cancer patients [10] and survivors [11], particularly 69 
on the quality of life of breast cancer patients during active treatment [12,13] and survivors post-70 
treatment [14,15]. Participation in physical activity interventions has also been reported to reduce 71 
levels of fatigue [3, 7, 16, 17], anxiety [18, 19], and depression [20]  and to improve self-esteem [16, 72 
18] and levels of physical activity in patients [16, 18, 21] and in survivors [3, 16, 23]. The evidence 73 
supporting the benefits of physical activity in breast cancer patients highlights the importance of 74 
encouraging patients to employ active lifestyles during treatment through to survivorship. 75 
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Physical activity interventions have varied in duration from 4 weeks [24] to 6 months [25] and have 76 
been delivered in both individual [18] and group settings [13]. However, interventions that are 77 
delivered in group settings, or that are hospital-based and/or supervised, can restrict participation  as 78 
patients undergoing chemotherapy are often busy with treatment schedules, are unwell or have limited 79 
access to exercise facilities due to transportation or scheduling difficulties [16]. To overcome such 80 
restrictions some researchers have moved towards the use of home-based, physical activity 81 
interventions for patients undergoing active treatment and report positive effects on psychosocial 82 
health outcomes [21, 25, 26]. However, some of these studies required regular facilitation by 83 
researchers or nursing staff. Although beneficial, such interventions are reported to be very time 84 
consuming for nurses and can also be expensive to run on a large scale.  A number of interventions 85 
have assessed the effectiveness of self-managed interventions with cancer patients and produced 86 
promising results, particularly for home-based exercise programmes among cancer patients, in 87 
relation to increasing physical activity and in improving psychosocial health outcomes [27, 28]. A key 88 
strength of such interventions is that they are easily accessible and encourage patients to be more 89 
physically active during treatment with minimal input from healthcare professionals.  Therefore self-90 
managed interventions are low intensity and are more likely to sustain behaviour change when the 91 
intervention ends as it is not reliant on feedback from experts [28]. 92 
Home-based physical activity interventions have previously shown to improve psychosocial 93 
functioning in breast cancer patients [21,25, 29] and survivors [16, 22]. However, these have been 94 
directed by researchers or nursing staff. Therefore, building on the need for more self-managed 95 
interventions, this study investigates the effectiveness of a 12 week self-managed, home-based 96 
walking intervention designed upon principles of The Theory of Planned Behaviour [30, 31]. The 97 
randomised controlled trial investigates the impact of walking on the psychosocial well-being of 98 
breast cancer patients receiving chemotherapy. The following hypotheses were tested: breast cancer 99 
patients who receive the walking intervention will report higher ratings of self-esteem, mood and 100 
physical activity and lower ratings of anxiety, depression and fatigue in comparison to the control 101 
group.  102 
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 103 
Method 104 
Design  105 
The study compared 12 weeks of self-managed moderate intensity walking plus usual care (n=25) to 106 
usual care alone (n=25). Assessments were conducted pre-intervention and 12 weeks later at post-107 
intervention. Ethical approval for the study was obtained from the Loughborough University Ethical 108 
Advisory Committee and the NHS Research Ethics Committee.  109 
 110 
Recruitment   111 
Participants were recruited from three outpatient clinics at the Leicester Royal Infirmary in the UK 112 
over a 16 month period. Patients with a diagnosis of breast cancer waiting to begin adjuvant or neo-113 
adjuvant chemotherapy and who were considered fit to take part in moderate intensity exercise by 114 
their oncologist, were invited to take part in the study. Women aged between 18 and 75 years were 115 
eligible for the study if they fulfilled the following criteria:  a primary diagnosis of stage I to III breast 116 
cancer; waiting to begin chemotherapy; able to read and speak English; able to walk unassisted; and 117 
were relatively inactive (<30min a day, 5 times a week of moderate intensity walking). Participants 118 
were excluded if they had prior history of cancer or if they had a current psychiatric illness that could 119 
hinder participation in the study procedures. 120 
 121 
Procedure  122 
Consenting participants were asked to complete all questionnaire measures of psychosocial health and 123 
subjective physical activity in the comfort of their own homes before beginning chemotherapy. 124 
Participants were asked to complete questionnaires a second time after they had completed 2 out of 6 125 
cycles of chemotherapy (pre-intervention). Participants were then randomised into either the 126 
intervention or control group. Participants began the walking intervention after 2cycles of treatment as 127 
oncologists suggested that the intervention would be better received after patients had begun 128 
chemotherapy and understood what they were facing. Those who were randomised into the physical 129 
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activity group were provided with intervention materials and those in the control group continued 130 
with usual care alone (medical care only). All participants completed the questionnaires for the third 131 
time 12 weeks later (post-intervention), after the completion of six cycles of chemotherapy (see figure 132 
one).  133 
 134 
Intervention 135 
The intervention consisted of 12 weeks of home-based, self-managed, moderate intensity walking 136 
compared with usual care alone. Patients were provided with an intervention booklet including (see 137 
appendix) guidance and recommendations to ensure adherence to the intervention, tips and 138 
encouragement outlining the benefits of walking, and a diary to keep a log of walking duration and 139 
intensity. A number of physical activity interventions for cancer patients and cancer survivors have 140 
been developed and evaluated using tenets of the (TPB) and have found that those receiving the TPB-141 
based interventions generally reported positive changes in their attitude toward, and participation in 142 
physical activity [30, 31].Therefore, this theory was used to design the self-management strategies in 143 
the home-based walking intervention booklet. A number of behavioural change techniques [32] based 144 
on the theory were incorporated as part of the intervention to help cancer patients plan their physical 145 
activity, set goals, self-monitor their progress and transform their intentions into actions  [33]. 146 
Walking schedules were self-managed; however, the researcher recommended that participants began 147 
by completing 10 minutes of walking and then steadily increased the duration of walking to 30 148 
minutes five times a week, in line with recommended guidelines [34].  149 
The intervention booklet encouraged participants to make weekly goals outlining intended exercise 150 
intensity, duration and timing (exactly when they intend to exercise). The booklet encouraged 151 
reflection by asking participants to write down their achievements or shortfalls from previous weeks 152 
and to take these into consideration by modifying goals to ensure they were realistic and achievable. 153 
The booklet reminded participants to take their chemotherapy schedule into consideration when 154 
setting goals, and to self-check that they did not over exert themselves or set unrealistic goals during 155 
weeks in which they received treatment. Patients were also provided with the researcher’s contact 156 
details if they had any questions regarding the intervention. 157 
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The intervention group were provided with a Yamax Digi-Walker SW-200 pedometer for the duration 158 
of the intervention to measure daily step count and to provide immediate feedback and encourage 159 
motivation during the 12 week period. They were asked to keep a daily exercise diary outlining the 160 
number of steps taken, duration of walking bouts and perceived exertion rates. Those randomised to 161 
the control group received usual care alone.   162 
 163 
Measures 164 
Demographic, disease and treatment information was gathered via medical records and recruitment 165 
questionnaires. The following assessments were conducted at familiarisation, pre and post 166 
intervention.    167 
 168 
Psychosocial measures (primary measures): Hospital Anxiety and Depression Scale (HADS) [35]  is 169 
made up of two subscales, including 7 questions concerned with levels of anxiety and the remaining 7 170 
with levels of depression. Physical and functional effects of fatigue were measured using The 171 
Functional Assessment of Cancer Therapy-Fatigue (FACT-F) [36].  The Self Esteem Scale (SES) [37] 172 
was used to measure positive and negative feelings about the self using a 10 item scale. The Profile of 173 
Mood States-Short Form (POMS-SF) [38] is a 37 item tool assessing transient, fluctuating and 174 
affective moods states and is made up of 6 subscales and has frequently been used in this population 175 
[39]. All measures are validated and have previously been used with breast cancer patients. 176 
Physical Activity measures (secondary measures):  Levels of perceived physical activity were 177 
measured using the General Practice Physical Activity Questionnaire [40]. Perceived exertion in the 178 
intervention group was monitored using the Borg Rating of Perceived Exertion Scale [41]. The 179 
Yamex Digi-walker SW-200 pedometer was worn by the intervention group and recorded the number 180 
of steps taken per day.   181 
Randomisation  182 
Block randomisation using four blocks was used to allocate patients into one of two groups by the 183 
researcher. Within each group of four patients, two were allocated to the intervention group and two 184 
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to the control group; the allocation of groups within each block were random. This method was used 185 
in preference to simple random allocation to ensure equal numbers of consecutive patients in both 186 
groups, as recruitment was staggered [42].  187 
 188 
Sample size    189 
The study was designed to detect a standardised effect size of 0.5 [43] for repeated measures ANOVA 190 
with a power of 0.80 and α set at 5% significance level. Thus, 26 participants were required to 191 
complete each arm of the intervention.   192 
 193 
Statistical analysis 194 
All analyses were carried out using IBM SPSS version 21.0 for Windows. All between-group 195 
differences of categorical variables were analysed using Pearson’s chi-square. Preliminary analyses 196 
compared baseline ratings of psychosocial health outcomes and perceived physical activity.  Non-197 
parametric tests were reported when Levene’s F test revealed that homogeneity of variance was 198 
violated.  199 
 200 
To examine the difference in primary measures of psychosocial health outcomes between the 201 
intervention and the control group over time, a series of 2 x 2 mixed analyses of variance (ANOVAs) 202 
were conducted comparing baseline and post intervention data. Frequency analyses were conducted in 203 
order to determine differences between groups in self-reported physical activity using a series of Chi-204 
square tests.  Intention to treat (ITT) analysis was used as it includes all randomised patients in the 205 
groups to which they were randomly assigned regardless of subsequent withdrawal from treatment or 206 
deviation from the protocol.   207 
 208 
 209 
 210 
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Results 211 
Of the 96 eligible participants 33 (34%) declined participation due to high levels of distress following 212 
their diagnosis. In total 63 breast cancer patients due to begin adjuvant and neo adjuvant 213 
chemotherapy met the inclusion criteria, consented to take part and completed recruitment measures 214 
(recruitment rate of 69%).  A further 13 participants were lost to attrition due to changes in treatment 215 
after providing consent. Therefore 50 participants were randomised to the intervention (n=25) or 216 
control group (n=25).  217 
Sample characteristics 218 
As displayed in Table 1, the overall age of participants in the intervention group ranged from 27-74 219 
years (mean = 52 years; SD = 11.7) and 29-66 years in the control group (mean = 52; SD = 8.9). 220 
There were no significant differences between groups in sociodemographic or treatment-related 221 
variables. Table 2 summarises demographic and cancer-related characteristics for participants who 222 
completed the study and those who withdrew following the familiarisation session. There was no 223 
significant difference in age between those who completed the study (mean = 52 years; SD = 10.29) 224 
and those who withdrew (mean = 55 years; SD = 12.67).  Those who withdrew from the study had 225 
lower educational qualifications and were less likely to be in employment. Participants did not differ 226 
on any other demographic or cancer-related characteristics.  227 
Baseline characteristics  228 
Using ITT, there were no significant between group differences in baseline measures of anxiety, 229 
depression, fatigue, self-esteem, mood or subjective ratings of physical activity. There was a small 230 
difference between groups in two subscales of mood: vigour and confusion. At baseline, those 231 
randomised to the intervention group presented with higher scores of vigour and lower scores of 232 
confusion. However, these differences were controlled for using a mixed measures analyses.   233 
 234 
 235 
 236 
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Adherence   237 
Adherence was calculated based upon the completion of the 12 week intervention. Twenty (80%) out 238 
of the twenty-five participants randomised to the physical activity group adhered to the intervention 239 
and completed walking diaries. Five participants discontinued participation within the first few weeks 240 
of the 12 week intervention and did not complete the diaries.  However, they completed all follow-up 241 
measures post-intervention.  Using ITT analysis we included their data in the main analysis. Reasons 242 
for discontinuing participation in the intervention included hospitalisation and medical complications. 243 
Of the 20 participants that continued with the intervention, 16 completed walking diaries on a weekly 244 
basis and four participants had one or more weeks of missing diary data due to hospitalisation, but 245 
continued with the intervention after they were discharged and completed all other measures.  246 
 247 
Effect of exercise intervention on psychosocial health outcomes  248 
As seen in Table 3, significant time x group interactions revealed positive effects of the intervention 249 
on fatigue F (1, 48) = 5.77; p = 0.02, self-esteem F (1, 48) = 8.93; p = 0.00 and mood F (1, 48) = 250 
4.73; p = 0.03. Significant intervention effects were also revealed for three out of the six subscales 251 
assessing mood, including vigour F (1, 48) = 11.23; p = 0.00, depression F (1, 48) = 4.09; p = 0.04 252 
and fatigue F (1, 48) = 5.34; p = 0.02. Ratings of confusion and anger did not reach significance; 253 
however, positive trends towards the intervention were revealed. Anxiety and depression as measured 254 
by the HADS improved in both groups across the intervention period with no significant intervention 255 
effects.  256 
 257 
Effect of exercise intervention on physical activity  258 
Post-intervention analysis revealed significant differences between groups in perceived levels of 259 
physical activity, x² (3, N=50) = 17.15, p = 0.001. When looking at groups individually, Table 4 260 
illustrates that the majority of the intervention group (36%) classed themselves as ‘active’ compared 261 
with no patients in the control group. Those who received the physical activity intervention altered 262 
their levels of physical activity from ‘inactive’ to ‘active’. In contrast, over half (56%) of the control 263 
group remained in the inactive group across the 12 week period.  264 
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Discussion  265 
The aim of this study was to assess the effectiveness of a self-managed physical intervention in 266 
improving psychosocial health outcomes and levels of physical activity among breast cancer patients 267 
receiving chemotherapy. The 12 week intervention demonstrated significant positive effects on 268 
fatigue, self-esteem, overall mood and in three subscales of the POMS-SF: vigour, depression and 269 
fatigue. Conversely, no intervention effects were revealed for anxiety and depression as measured 270 
using the HADS or tension as measured using the POMS-SF. Overall, findings from the current study 271 
are encouraging and contribute new knowledge as they indicate that a self-managed, home-based 272 
physical activity intervention based upon the TPB can be successfully implemented to improve 273 
psychosocial health outcomes and physical activity among breast cancer patients actively receiving 274 
chemotherapy treatment. Furthermore, positive findings indicate the efficacy of self-managed 275 
interventions within this population without the need for individualised, supervised sessions which 276 
require specialist input, or additional support from healthcare professionals.  277 
Our walking intervention increased self-reported physical activity levels which is promising as it 278 
demonstrates that a self-managed walking intervention can be successful without the need for 279 
additional  280 
Increased levels of self-reported physical activity following our walking intervention are promising as 281 
they indicate positive effects of our self-managed intervention without the need for individualised 282 
sessions proposed in previous home-based interventions among breast cancer patients [21, 25] . 283 
Improving levels of physical activity in breast cancer patients has important implications for reducing 284 
risk of cancer reoccurrence and improving survival rate and mortality [9].  285 
The self-managed intervention had a positive effect on fatigue and contributes to the evidence from 286 
previous physical activity interventions with breast cancer patients [7, 16, 23, 26]. The intervention 287 
also provides further support for the benefits of physical activity for self-esteem in breast cancer 288 
patients [18]. Positive effects on self-esteem for an intervention that is implemented during 289 
chemotherapy is particularly interesting, as treatment for breast cancer can result in negative effects 290 
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on body image and perceived femininity [44]. Therefore, a self-managed home-based walking 291 
intervention which can help to improve self-esteem during treatment should be encouraged and 292 
implemented on a larger scale.  Positive effects of the intervention on self-esteem may also be due to 293 
the sense of achievement felt after setting and achieving self-prescribed walking goals. Further 294 
research and/or interventions are required to test this possibility.  295 
A significant intervention effect was revealed on total mood disturbance in line with previous home-296 
based physical activity interventions [16, 26]. These findings are of particular interest as they 297 
demonstrate the benefits of the physical activity intervention on mood without the need for additional 298 
counselling or social support from either a nurse or through cancer group based support. Interestingly, 299 
anger increased in our control group and decreased in our intervention group across the 12 week 300 
intervention period. Although results did not reach significance, these results are important as they 301 
suggest that self-managed physical activity might help to improve feelings of anger in breast cancer 302 
patients during chemotherapy.  Similarly, intervention effects on improving feelings of confusion 303 
were promising but did not reach significance.  304 
The intervention had no significant effects on anxiety and depression as measured by the HADS or 305 
tension as measured by the POMS-SF. It should be noted, however, that all three constructs improved 306 
in both groups across the 12 week period from mid-chemotherapy to post-chemotherapy. These 307 
results, therefore, suggest that these aspects of psychosocial health may improve naturally over time. 308 
There is some evidence on depression to support this whereby levels of  depression have been found 309 
to decrease naturally over time in cancer patients [45]. 310 
Strengths of our study include the direct comparison of walking to usual care alone in a homogenous 311 
sample of breast cancer patients undergoing chemotherapy. The success of the intervention designed 312 
using the principles of TPB, the use of ITT analyses and validated measures of psychosocial 313 
functioning also add to the strength of our study. In addition, both groups received the same level of 314 
researcher attention, confirming that improvements in psychosocial outcome in our treatment group 315 
were the result of the intervention as opposed to increased attention.  316 
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Key strengths of our study include the self-managed, home-based nature of the walking intervention 317 
along with its low cost design, which requires no face-to-face contact, guidance throughout the 318 
intervention or any exercise equipment. Furthermore, unlike previous home-based interventions, the 319 
current study did not require additional telephone contact or counselling with health care professionals 320 
and required no additional burden upon staff. Therefore, the current intervention makes a promising 321 
contribution to current literature and has important implications for the development of self-managed 322 
interventions that can benefit a large number of cancer patients.  323 
Limitations include the relatively small sample size and the lack of generalizability, as participants 324 
were all recruited from the same centre. Furthermore, the exclusion of participants who were unable 325 
to speak and read English resulted in eliminating participants from diverse ethnic backgrounds. The 326 
lack of follow-up measures after completion of the intervention and treatment (e.g. three months post-327 
intervention) is a limitation of the current study. Future intervention studies should include assessment 328 
of psychosocial health outcomes at three to six months post-intervention in order to investigate if 329 
benefits of exercise are short term or if there are additional long term benefits. Follow-up assessments 330 
would also allow researchers to see if participants continue with the walking post-intervention and 331 
adapt exercise into their daily routines or if they revert back to being sedentary.  332 
In summary, this randomised controlled trial was successful in providing health care professionals 333 
with an efficient, self-managed intervention to improve fatigue, mood and self-esteem and the overall 334 
quality of life of breast cancer patients actively undergoing chemotherapy. Providing patients with the 335 
ability to self-manage their own exercise schedules is less onerous on oncology staff and nurses and 336 
therefore can be introduced on a large scale. Furthermore, our intervention results indicate that a 337 
home-based, self-managed, moderate intensity intervention can successfully be incorporated around 338 
treatment schedules for breast cancer patients undergoing treatment. However, further intervention 339 
research with a large sample size and with other types of cancer patients is planned to confirm 340 
preliminary findings.  341 
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Total number of patients 
eligible, n = 96
Completed  familiarisation/ 
pre-chemotherapy 
(Time one), n = 63
Completed  mid-way 
assessment: 2-3 cycles of 
chemo (Time two), n = 50
Randomisation
Intervention group 
(12 week physical 
activity), n = 25
Control group 
(usual care alone) 
n = 25
Completed 
intervention, n = 20
Completed 12 weeks of 
usual care, n = 25
Completed post chemo 
assessment
 (Time three)
 n = 21
Completed post-chemo 
assessment
 (Time three) 
  n = 21
 Total not eligible n = 68
Not receiving chemotherapy = 26
Non-fluent in English n = 14
Medical complications n= 9
Psychological issues n = 8
Too active n = 7
Unable to exercise n= 4 
Total attrition n= 13
Change of treatment n =6
Medical difficulties n= 4
Other n =2
Too busy n= 1
Total 
Completed 
study, n =50
Total number of patients 
approached n= 164
Declined 
participation, 
n = 33
Total intervention
 attrition n = 5
Hospitalisation n = 4
Medical difficulties n =  1
 342 
Figure 1: Study recruitment and attrition rates  343 
 344 
  345 
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Table 1: Demographic and treatment characteristics for intervention and control group 346 
Characteristic Intervention (n=25) Control (n=25) 
 
 
Age (years)   M (SD) 
 
BMI              M (SD) 
    52.08          (11.7) 
 
    27.20          (4.82) 
     52.36          (8.9) 
 
    28.25          (5.83) 
p = .500 
 
p =.501 
 N % N % x² 
Education 
None 
GCSE (or equivalent) 
A level (or equivalent) 
Degree 
Higher Degree  
 
3 
11 
3 
5 
3 
 
 
12 
44 
12 
20 
12 
 
 
6 
9 
7 
2 
1 
 
24 
36 
28 
8 
4 
 
 
 
 
 
 
.279 
Marital status 
Single 
Married/living with 
partner 
Separated/divorced 
Widowed 
 
 
2 
19 
 
3 
1 
 
8 
76 
 
12 
4 
 
3 
19 
 
2 
1 
 
12 
76 
 
8 
4 
 
 
 
 
 
.940 
Employment status 
Working 
Sick leave 
Retired 
 
5 
17 
3 
 
 
20 
68 
12 
 
 
5 
16 
4 
 
 
20 
64 
16 
 
 
 
 
.917 
Breast cancer type 
Invasive ductal 
Invasive lobular 
 
24 
1 
 
96 
4 
 
23 
2 
 
92 
8 
 
 
.552 
Cancer grade 
I 
II 
III 
 
0 
5 
20 
 
0 
20 
80 
 
1 
8 
16 
 
4 
32 
64 
 
 
 
.344 
Chemotherapy type 
FEC 
FEC-T 
 
12 
13 
 
48 
52 
 
9 
16 
 
36 
64 
 
 
 
.390 
Treatment type 
Adjuvant 
Neo-adjuvant 
 
20 
5 
 
80 
20 
 
21 
4 
 
84 
16 
 
 
 
.713 
Surgery type 
Lumpectomy 
Mastectomy 
Segmental  
 
17 
7 
1 
 
68 
28 
4 
 
15 
10 
0 
 
60 
40 
0 
 
 
 
.437 
16 
 
 
Menopausal status 
Pre-menopausal  
Post-menopausal 
 
Self-report physical 
activity 
Inactive 
Moderately inactive 
Moderately active 
Active 
 
 
12 
13 
 
 
 
16 
4 
5 
0 
 
 
48 
52 
 
 
 
64 
16 
20 
0 
 
 
7 
18 
 
 
 
15 
4 
6 
0 
 
 
28 
72 
 
 
 
60 
16 
24 
0 
 
 
 
.150 
 
 
 
 
 
 
.940 
Note. FEC (fluorouracil, epirubicin and cyclophosphamide); FET-T (FEC followed by taxotere). 347 
 348 
349 
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 350 
Table 2: Demographic and treatment characteristics for completed and withdrawn participants 351 
Characteristic 
 
Completed (n=50) Withdrawn (n=13)  
Age (years) , M (SD) 
 
BMI             M (SD) 
      52             (10.29) 
   
  27.72           (5.14)                          
      55               (12.67) 
     
28.96           (4.07) 
p = .399 
 
p = .427 
 N % N % x² 
Education 
None 
GCSE (or equivalent) 
A level (or equivalent) 
Degree 
Higher Degree  
 
9 
20 
10 
7 
4 
 
 
18 
40 
20 
14 
8 
 
 
5 
4 
1 
3 
0 
 
38 
31 
8 
23 
0 
 
 
 
 
 
 
.000 
Marital status 
Single 
Married/living with 
partner 
Separated/divorced 
Widowed 
 
 
5 
38 
 
5 
2 
 
10 
76 
 
10 
4 
 
1 
9 
 
2 
1 
 
7 
69 
 
15 
8 
 
 
 
 
 
.877 
Employment status 
Working 
Sick leave 
Retired 
 
10 
33 
7 
 
 
20 
66 
14 
 
 
0 
8 
5 
 
 
0 
61 
38 
 
 
 
 
.053 
Breast cancer type 
Invasive ductal 
Invasive lobular 
 
47 
3 
 
94 
6 
 
13 
0 
 
100 
8 
 
 
.365 
Cancer grade 
I 
II 
III 
 
1 
13 
36 
 
2 
26 
72 
 
2 
2 
9 
 
15 
15 
69 
 
 
 
.112 
Chemotherapy type 
FEC 
FEC-T 
 
21 
29 
 
42 
58 
 
9 
4 
 
69 
30 
 
 
 
.080 
Treatment type 
Adjuvant 
Neo-adjuvant 
 
41 
9 
 
82 
18 
 
10 
3 
 
77 
23 
 
 
 
.678 
Surgery type 
Lumpectomy 
Mastectomy 
Segmental  
 
Menopausal Status 
Pre-menopausal 
Post-menopausal 
 
Self-report physical 
activity 
Inactive 
Moderately inactive 
Moderately active 
Active 
 
32 
17 
1 
 
 
19 
31 
 
 
 
31 
8 
11 
0 
 
64 
34 
2 
 
 
32 
62 
 
 
 
62 
16 
22 
0 
 
10 
2 
1 
 
 
4 
9 
 
 
 
12 
1 
0 
0 
 
77 
15 
8 
 
 
30 
69 
 
 
 
92 
7 
0 
0 
 
 
 
.287 
 
 
 
.630 
 
 
 
 
 
 
.323 
Note. FEC (fluorouracil, epirubicin and cyclophosphamide); FET-T (FEC followed by taxotere).352 
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Table 3: Independent t-tests for intervention group (n = 25) and control group (n = 25) at pre-intervention (preliminary results), post-intervention and  mixed measures ANOVA between time and group  
Variable Pre-intervention  Post-intervention  Group Time Time x Group 
 Intervention 
M  (SD) 
Control 
M  (SD) 
 
p 
Intervention 
M  (SD) 
Control 
M  (SD) 
 
 
  
HADS 
Anxiety 
 
 
4.40 (2.79) 
 
 
5.28 (3.54) 
 
 
0.33 
 
 
2.12 (1.83) 
 
 
3.80 (3.23) 
 
 
F=3.70 
 p=0.06 
 
 
F=15.90 
p=0.00 
 
 
F=0.90 
p=0.35 
Depression 5.52 (3.79)  6.68 (4.00) 0.30 4.44 (3.37) 
 
6.16 (2.21) 
 
F=3.23  
p 0.79 
F=2.17 
p=0.14 
F=0.26 
p=0.60 
POMS-SF 
Tension 
 
6.08 (4.14) 
 
8.60 (6.22) 
 
0.09 ͣ
 
 
3.00 (3.76) 
 
 
6.80 (4.37) 
 
 
F=7.60 
 p=0.00 
 
 
F=12.62 
p=0.00 
 
 
F=0.86 
p=0.35 
Vigour 
 
10.56 (4.77) 
 
7.92 (3.82) 
 
0.04* 
 
14.04 (3.70) 
 
7.52 (4.36) 
 
F=19.61 
 p=0.00 
F=7.07 
p=0.01 
F=11.23 
p=0.00 
Depression 
 
4.92 (5.31) 
 
6.68 (5.72) 
 
0.27 
 
1.68 (2.01) 
 
6.44 (4.99) 
 
F=8.50 
 p=0.00 
 
F=5.50 
p=0.02 
 
F=4.09 
p=0.04 
Fatigue 
 
8.28 (5.46) 
 
10.00 (5.71) 
 
0.28 4.20 (3.35) 
 
9.24 (4.73) 
 
F=8.11 
 p=0.00 
F=11.35 
p=0.00 
F=5.34 
p=0.02 
Anger 
 
2.68 (2.23) 
 
3.92 (3.95) 
 
0.20 ͣ
 
2.00 (2.79) 
 
4.92  (3.96) 
 
F=6.87 
 p=0.01 
F=0.10 
p=0.75 
F=2.77 
p=0.10 
Confusion 
 
2.68 (2.23) 
 
5.76 (4.18) 
 
0.02*ͣ 
 
1.84 (1.37) 5.52 (3.69) F=15.43 
p=0.00 
F=5.09 
p=0.02 
F=2.86 
p=0.09 
Total Mood 15.88 (21.22) 28.32 (26.86) 0.08 4.20 (14.67) 27.76 (21.35) F=10.67 
 p=0.00 
F=5.73 
p=0.02 
F=4.73 
p=0.03 
FACT-F  
Fatigue 
 
 
32.16 (8.42) 
 
34.24 (9.48) 
 
0.41 
 
26.04 (3.80) 
 
33.60 (7.29) 
 
F=7.10 
 p=0.01 
 
F=8.78 
p=0.00 
 
F=5.77 
p=0.02 
SES  
Self-esteem  
 
 
21.68 (4.43) 
 
20.44 (4.94) 
 
0.62 
 
23.80 (4.59) 
 
19.52 (4.18) 
 
F=8.93 
 p=0.00 
 
F=1.39 
p=0.24 
 
F=8.93 
p=0.00 
HADS, Hospital Anxiety and Depression Scale, POMS-SF Profile of Mood States-Short Form, FACT-F The Functional Assessment of Cancer therapy-Fatigue,  
SES Rosenberg Self-esteem Scale, M, Mean, SD, standard deviation; *p<0.05; **p<0.01. ͣ Mann Whitney U (assumption of homogeneity of variance violated) 
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Table 4: Chi-square analysis between intervention (n=25) and control group (n=25) at pre and post-intervention.   
 
 
  
   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Variable 
Time one 
(pre-intervention) 
             Time two 
               (post-intervention) 
 
 Intervention 
(n=25) 
 
Control 
(n=25) 
 
 
Result 
Intervention 
(n=25) 
 
Control 
(n=25) 
 
 
Result 
 
 N % N % x² N % N % x² 
Perceived physical 
activity  
 
Inactive 
Moderately inactive  
Moderately active 
Active 
 
 
 
16 
4 
5 
0 
 
 
 
64 
16 
20 
0 
 
 
 
15 
4 
6 
0 
 
 
 
60 
16 
24 
0 
 
 
 
 
 
 
 
   .940 
 
 
 
4 
6 
6 
9 
 
 
 
16 
24 
24 
36 
 
 
 
14 
9 
2 
0 
 
 
 
56 
36 
8 
0 
 
 
 
 
 
 
 
  .001 
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